Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 2,420,231 | 88,832,720 (143%) | 3% | 0 | Class C Common Stock, par value $0.001 per share | |
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Executive Chairman, Ten Percent Owner | 03 Oct 2022 | 2,420,231 | 2,420,231 (3%) | 3% | 0 | Class A Common Stock | ||
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Executive Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 2,420,231 | 0 (0%) | 3% | 0 | Class A Common Stock | |
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Executive Chairman, Ten Percent Owner | 03 Oct 2022 | 2,420,231 | 88,832,720 | - | - | Common Units | ||
| Absci Corp | Andreas Busch | Chief Innovation Officer | 03 Oct 2022 | 2,000,009 | 2,000,009 | - | - | Stock Option (right to buy) | ||
| Biohaven Ltd | John W. Childs | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 1,512,500 | 1,517,110 | - | 0 | Common Shares | |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 1,291,829 | 1,291,829 | - | 0 | Common Shares | |
| Advantage Soln Inc (Class A) | Brian Stevens | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 1,170,000 | 1,170,000 | - | - | Stock Option (Right to Buy) | |
| Gitlab Inc (Class A) | Michael McBride | Chief Revenue Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Oct 2022 | 896,506 | 58,736 | - | 0 | Class A Common Stock | |
| Fluent Inc | Donald Patrick | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 459,500 | 929,500 (1%) | 0% | 0 | Common Stock | |
| Fluent Inc | Donald Patrick | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 459,500 | 1,389,000 (1%) | 0% | 0 | Common Stock | |
| Codexis Inc | Kevin Norrett | Chief Operating Officer | 03 Oct 2022 | 413,405 | 413,405 | - | - | Stock Option (Right to Buy) | ||
| Prologis | James B. Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 404,127 | 404,127 | - | - | Units | |
| KKR | Kathryn King Sudol | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 400,000 | 400,000 | - | - | Restricted Holdings Units | |
| HP Inc. | Julie M. Jacobs | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 347,625 | 347,625 | - | - | Restricted Stock Units | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Bruce Car | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 249,130 | 249,130 | - | 0 | Common Shares | |
| Senti Biosciences Inc | Deborah Knobelman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Ranpak Holdings Corp (Class A) | Salil Seshadri | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Oct 2022 | 214,016 | 214,016 (0%) | 0% | - | Class A common stock | |
| Ranpak Holdings Corp (Class A) | Salil Seshadri | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Oct 2022 | 214,016 | 325,397 (0%) | 0% | - | Class A common stock | |
| Advantage Soln Inc (Class A) | Brian Stevens | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 200,892 | 200,892 | - | - | Performance Restricted Stock Unit | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 156,750 | 156,750 | - | 0 | Common Shares | |
| American Strategic Investment Co (Class A) | Edward M. Weil | Director, CEO, President and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 146,284 | 560,177 | - | 0 | Class A Common Stock | |
| American Strategic Investment Co (Class A) | Nicholas S. Schorsch | Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 146,284 | 560,177 | - | 0 | Class A common stock | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 130,677 | 130,677 | - | - | Restricted Stock Units | |
| Boston Scientific | Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 39.34 per share. | 03 Oct 2022 | 125,827 | 1,767,665 (0%) | 0% | 39.3 | 4,949,556 | Common Stock |
| Biohaven Ltd | Julia P. Gregory | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 125,000 | 125,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 125,000 | 125,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kishan Mehta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 125,000 | 125,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Irina Antonijevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 125,000 | 125,000 | - | - | Stock Options (Right to Buy) | |
| Advantage Soln Inc (Class A) | Brian Stevens | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 125,000 | 406,082 | - | 0 | Class A Common Stock | |
| Keurig Dr Pepper | Robert J. Gamgort | Director, Executive Chairman | 03 Oct 2022 | 125,000 | 4,128,186 (0%) | 0% | 36.1 | 4,512,500 | Common Stock | |
| Prologis | James B. Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 124,405 | 528,532 | - | - | Units | |
| P&G | Jon R. Moeller | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 122,095 | 122,095 | - | - | Stock Option (Right to Buy) | |
| Fluent Inc | Carla S. Newell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 115,385 | 259,972 (0%) | 0% | 0 | Common Stock | |
| Fluent Inc | Barbara Z. Shattuck Kohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 115,385 | 296,100 (0%) | 0% | 0 | Common Stock | |
| Fluent Inc | Donald Mathis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 115,385 | 387,922 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Edward Stelmakh | CFO/COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 97,637 | 97,637 | - | - | Stock Option | |
| Woodward Inc | Charles P. Blankenship | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 95,288 | 95,288 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Tandy Leather Factory Inc | Janet Carr | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 92,000 | 92,000 | - | - | Restricted Stock Units | |
| Tandy Leather Factory Inc | Janet Carr | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 92,000 | 404,049 (4%) | 1% | 0 | Common Stock | |
| Boston Scientific | Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 82,567 | 82,567 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.39 per share. | 03 Oct 2022 | 82,567 | 1,850,232 (0%) | 0% | 7.4 | 610,170 | Common Stock |
| Americas Car Mart Inc | Douglas W. Campbell | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 75,000 | 75,000 | - | - | Employee Stock Option (Right to Buy) | |
| Payoneer Global Inc | Arnon Kraft | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.22 per share. | 03 Oct 2022 | 73,000 | 539,782 | - | 6.2 | 453,812 | Common Stock |
| Prologis | James B. Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 70,756 | 70,756 (0%) | 0% | - | Common Stock | |
| Privia Health Group Inc | Thomas Bartrum | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 68,072 | 266,228 | - | - | Stock Option (Right to Purchase) | |
| Privia Health Group Inc | Thomas Bartrum | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 03 Oct 2022 | 68,072 | 159,427 | - | 2 | 136,144 | Common Stock, $0.01 par value per share |
| Jazz Pharma PLC | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 62,905 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Bruce C. Cozadd | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.13 per share. | 03 Oct 2022 | 62,905 | 419,213 (0%) | 0% | 59.1 | 3,719,573 | Ordinary Shares |
| FTC Solar Inc | David Springer | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.13 per share. | 03 Oct 2022 | 62,306 | 6,350,806 | - | 3.1 | 195,018 | Common Stock |
| FTC Solar Inc | David Springer | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.31 per share. | 03 Oct 2022 | 62,306 | 6,288,500 | - | 3.3 | 206,233 | Common Stock |
| P&G | Fatima Ma. Francisco | CEO - Baby, Fem & Family Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 61,469 | 61,469 | - | - | Stock Option (Right to Buy) | |
| MillerKnoll Inc | Andrea R. Owen | President & CEO | Purchase of securities on an exchange or from another person at price $ 16.88 per share. | 03 Oct 2022 | 60,606 | 100,468 (0%) | 0% | 16.9 | 1,022,963 | Common Stock |
| Fluent Inc | Carla S. Newell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 58,778 | 144,587 (0%) | 0% | 0 | Common Stock | |
| Fluent Inc | Barbara Z. Shattuck Kohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 58,778 | 180,715 (0%) | 0% | 0 | Common Stock | |
| Fluent Inc | Donald Mathis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 58,778 | 272,537 (0%) | 0% | 0 | Common Stock | |
| P&G | Sundar G. Raman | CEO-Fabric & Home Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 58,396 | 58,396 | - | - | Stock Option (Right to Buy) | |
| P&G | Marc S. Pritchard | Chief Brand Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 51,462 | 51,462 | - | - | Stock Option (Right to Buy) | |
| International Seaways Inc | Lois K. Zabrocky | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 51,314 | 0 | - | - | Stock Option (Right to Buy) | |
| International Seaways Inc | Lois K. Zabrocky | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.21 per share. | 03 Oct 2022 | 51,314 | 164,145 (0%) | 0% | 17.2 | 883,114 | Common Stock, no par value per share |
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 50,000 | 694,377 (0%) | 0% | 19.4 | 967,500 | Common Shares | |
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 50,000 | 694,377 (0%) | 0% | 19.4 | 967,500 | Common Shares | |
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 50,000 | 644,377 (0%) | 0% | 45.7 | 2,282,825 | Common Shares | |
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 50,000 | 694,377 (0%) | 0% | 19.4 | 967,500 | Common Shares | |
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 50,000 | 644,377 (0%) | 0% | 45.8 | 2,290,465 | Common Shares | |
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 50,000 | 1,450,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 50,000 | 1,400,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 50,000 | 1,350,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Zentalis Pharma Inc | Melissa B. Epperly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 50,000 | 297,543 | - | 0 | Common Stock | |
| Zentalis Pharma Inc | Kevin D. Bunker | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharma Inc | Kevin D. Bunker | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 50,000 | 814,110 | - | 0 | Common Stock | |
| OptimizeRx Corp | Edward Stelmakh | CFO/COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 49,867 | 49,867 | - | - | Restricted Stock Units | |
| Genpact Ltd | N. V. Tyagarajan | Director, President and CEO | 03 Oct 2022 | 49,700 | 644,677 (0%) | 0% | 44.5 | 2,210,089 | Common Shares | |
| P&G | R. Alexandra Keith | CEO - Beauty | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 49,038 | 49,038 | - | - | Stock Option (Right to Buy) | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 49,004 | 49,004 | - | - | Restricted Stock Units | |
| Traeger Inc | Steven Philip Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 47,168 | 47,168 | - | 0 | Common Stock | |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 46,025 | 622,284 | - | 0 | Common Shares | |
| P&G | M. Tracey Grabowski | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 45,245 | 45,245 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.08 per share. | 03 Oct 2022 | 43,260 | 1,893,492 (0%) | 0% | 13.1 | 565,841 | Common Stock |
| Boston Scientific | Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 43,260 | 216,301 | - | - | Stock Option (Right to Buy) | |
| P&G | Victor Javier Moses Aguilar | Chf Rsch, Dev & Innov Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 42,557 | 42,557 | - | - | Stock Option (Right to Buy) | |
| P&G | Shailesh G. Jejurikar | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 42,102 | 42,102 | - | - | Stock Option (Right to Buy) | |
| Occidental Petroleum | Sylvia J Kerrigan | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 40,587 | 40,587 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 39,055 | 39,055 | - | - | Stock Option | |
| OptimizeRx Corp | Marion Odence-Ford | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 39,055 | 39,055 | - | - | Stock Option | |
| International Seaways Inc | Lois K. Zabrocky | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.99 per share. | 03 Oct 2022 | 38,511 | 125,634 (0%) | 0% | 35.0 | 1,347,500 | Common Stock, no par value per share |
| P&G | Andre Schulten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 37,892 | 37,892 | - | - | Stock Option (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. | 03 Oct 2022 | 37,492 | 95,969 | - | 7 | 262,444 | Common Shares |
| Privia Health Group Inc | Thomas Bartrum | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 33.82 per share. | 03 Oct 2022 | 35,957 | 123,470 | - | 33.8 | 1,216,066 | Common Stock, $0.01 par value per share |
| MGM Resorts International | Jonathan S. Halkyard | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 35,936 | 35,936 | - | - | Restricted Stock Units | |
| Honeywell | Lucian Boldea | President and CEO, PMT | 03 Oct 2022 | 35,187 | 35,187 | - | - | Employee Stock Options | ||
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 200.02 per share. | 03 Oct 2022 | 35,000 | 199,753 (0%) | 0% | 200.0 | 7,000,700 | Class A Common Stock |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 35,000 | 18,036 | - | - | Employee Stock Option (Right to Buy) | |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. | 03 Oct 2022 | 35,000 | 234,753 (0%) | 0% | 6.5 | 227,500 | Class A Common Stock |
| Tandy Leather Factory Inc | Janet Carr | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Oct 2022 | 34,362 | 369,687 (4%) | 0% | 0 | Common Stock | |
| HP Inc. | Enrique Lores | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.23 per share. | 03 Oct 2022 | 34,000 | 517,204 (0%) | 0% | 25.2 | 857,820 | Common Stock |
| Bloomin Brands Inc | Suzann Trevisan | Chief Human Resources Officer | 03 Oct 2022 | 32,661 | 32,661 | - | - | Restricted Stock Units | ||
| Privia Health Group Inc | Thomas Bartrum | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 34.40 per share. | 03 Oct 2022 | 32,115 | 91,355 | - | 34.4 | 1,104,756 | Common Stock, $0.01 par value per share |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 31,261 | 4,596,745 | - | - | Stock Option (Right to Purchase) | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 03 Oct 2022 | 31,261 | 153,000 | - | 2 | 62,522 | Common Stock, $0.01 par value per share |
| Woodward Inc | Thomas G. Cromwell | Vice Chairman, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 31,181 | 31,181 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| P&G | Gary A. Coombe | CEO - Grooming | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 31,156 | 31,156 | - | - | Stock Option (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 03 Oct 2022 | 30,958 | 93,908 | - | 1.6 | 49,842 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 30,958 | 30,958 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 30,958 | 0 | - | - | Stock Options (Right to Buy) | |
| Rocket Companies Inc (Class A) | Jay Farner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.51 per share. | 03 Oct 2022 | 30,700 | 4,478,507 | - | 6.5 | 199,857 | Class A common stock |
| OppFi Inc (Class A) | Todd G. Schwartz | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Oct 2022 | 30,000 | 95,129,100 | - | 0 | Class V Common Stock | |
| Senti Biosciences Inc | Deborah Knobelman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 30,000 | 30,000 | - | 0 | Common Stock | |
| Netflix | Reed Hastings | Director, Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 29,632 | 29,632 | - | - | Non-Qualified Stock Option (right to buy) | |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 29,403 | 29,403 | - | - | Restricted Stock Units | |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.49 per share. | 03 Oct 2022 | 29,300 | 108,535 (0%) | 0% | 30.5 | 893,357 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Sale of securities on an exchange or to another person at price $ 66.30 per share. | 03 Oct 2022 | 29,300 | 79,235 (0%) | 0% | 66.3 | 1,942,693 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 29,300 | 0 | - | - | Employee Stock Option (right to buy) | |
| P&G | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 29,198 | 29,198 | - | - | Stock Option (Right to Buy) | |
| Rocket Companies Inc (Class A) | Jay Farner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.92 per share. | 03 Oct 2022 | 28,800 | 4,535,707 | - | 6.9 | 199,296 | Class A common stock |
| Rocket Companies Inc (Class A) | Jay Farner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.03 per share. | 03 Oct 2022 | 28,400 | 4,506,907 | - | 7.0 | 199,652 | Class A common stock |
| Aqua Metals Inc | David L. Kanen | Director | Grant, award, or other acquisition of securities at price $ 0.76 per share. | 03 Oct 2022 | 28,223 | 28,223 (0%) | 0% | 0.8 | 21,449 | Common Shares |
| P&G | Jon R. Moeller | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 28,208 | 229,431 (0%) | 0% | 0 | Common Stock | |
| NexPoint Diversified Real Estate Trust | James D. Dondero | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.24 per share. | 03 Oct 2022 | 27,781 | 3,789,355 (8%) | 0% | 13.2 | 367,820 | Common Stock |
| Enovix Corp | Gardner Cameron Dales | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.96 per share. | 03 Oct 2022 | 26,198 | 933,367 | - | 18.0 | 470,516 | Common Stock |
| Hydrofarm Holdings Grp Inc | William Toler | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.94 per share. | 03 Oct 2022 | 25,441 | 1,616,777 | - | 1.9 | 49,356 | Common Stock, $0.0001 par value per share |
| ClearSign Tech Corp | Judith S. Schrecker | Director | 03 Oct 2022 | 25,397 | 25,397 | - | - | Restricted Stock Units | ||
| ChargePoint Holdings Inc (Class A) | Michael D. Hughes | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.56 per share. | 03 Oct 2022 | 25,000 | 980,094 | - | 0.6 | 14,000 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Michael D. Hughes | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 25,000 | 1,191,174 | - | - | Stock Option (right to buy) | |
| ChargePoint Holdings Inc (Class A) | Michael D. Hughes | See Remarks | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 03 Oct 2022 | 25,000 | 955,094 | - | 15.1 | 377,865 | Common Stock |
| Privia Health Group Inc | Thomas Bartrum | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 25,000 | 241,228 | - | - | Stock Option (Right to Purchase) | |
| Privia Health Group Inc | Thomas Bartrum | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 03 Oct 2022 | 25,000 | 116,355 | - | 2 | 50,000 | Common Stock, $0.01 par value per share |
| Privia Health Group Inc | Thomas Bartrum | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 35.37 per share. | 03 Oct 2022 | 25,000 | 91,355 | - | 35.4 | 884,250 | Common Stock, $0.01 par value per share |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 25.64 per share. | 03 Oct 2022 | 25,000 | 56,462 (0%) | 0% | 25.6 | 641,000 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 25,000 | 57,602 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 03 Oct 2022 | 25,000 | 81,462 (0%) | 0% | 3.3 | 82,250 | Common Stock |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 03 Oct 2022 | 24,877 | 128,123 | - | 35.0 | 870,944 | Common Stock, $0.01 par value per share |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 24,312 | 24,312 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 24,312 | 343,208 (0%) | 0% | - | Common Stock | |
| ClearSign Tech Corp | Susanne L. Meline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 24,088 | 24,088 | - | - | Restricted Stock Units | |
| Honeywell | Lucian Boldea | President and CEO, PMT | 03 Oct 2022 | 23,817 | 23,817 | - | - | Restricted Stock Units | ||
| ACV Auctions Inc (Class A) | George G. Chamoun | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Oct 2022 | 23,691 | 4,964,618 | - | - | Class B Common Stock | |
| Jazz Pharma PLC | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 135.18 per share. | 03 Oct 2022 | 23,646 | 381,776 (0%) | 0% | 135.2 | 3,196,386 | Ordinary Shares |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 23,461 | 4,628,006 | - | - | Stock Option (Right to Purchase) | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 03 Oct 2022 | 23,461 | 145,200 | - | 2 | 46,922 | Common Stock, $0.01 par value per share |
| Axe Compute Inc | Daniel E. Handley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 23,147 | 104,513 (2%) | 0% | 0 | Common Stock | |
| Axe Compute Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 23,147 | 354,015 (8%) | 0% | 0 | Common Stock | |
| Axe Compute Inc | Nancy Chung-Welch | Director | 03 Oct 2022 | 23,147 | 131,991 (3%) | 0% | 0 | Common Stock | ||
| Axe Compute Inc | Gregory S. St.Clair | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 23,147 | 120,547 (2%) | 0% | 0 | Common Stock | |
| Medical Properties Trust Inc | Edward K. Aldag | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.84 per share. | 03 Oct 2022 | 22,936 | 3,451,334 (0%) | 0% | 11.8 | 271,562 | Common stock, par value $0.001 |
| PepGen Inc | Habib J. Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 22,686 | 22,686 | - | - | Stock Option (Right to Buy) | |
| Palo Alto | Nir Zuk | Director, EVP, Chief Technology Officer | 03 Oct 2022 | 21,600 | 1,954,936 (1%) | 0% | 168.2 | 3,633,487 | Common Stock | |
| P&G | Susan Street Whaley | Chief Legal Officer & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 21,456 | 21,456 | - | - | Stock Option (Right to Buy) | |
| ClearSign Tech Corp | Robert T. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 20,946 | 20,946 | - | - | Restricted Stock Units | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Oct 2022 | 20,716 | 116,461 | - | 1.0 | 21,337 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 20,716 | 20,716 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 20,716 | 0 | - | - | Stock Options (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.15 per share. | 03 Oct 2022 | 20,700 | 99,935 (0%) | 0% | 33.2 | 686,205 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 20,700 | 4,300 | - | - | Employee Stock Option (right to buy) | |
| Alignment Healthcare Inc | Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 03 Oct 2022 | 20,000 | 1,187,226 | - | 12.0 | 240,508 | Common Stock |
| Americas Car Mart Inc | Douglas W. Campbell | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 19,947 | 19,947 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Marion Odence-Ford | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 19,947 | 19,947 | - | - | Restricted Stock Units | |
| Otis Worldwide | Anurag Maheshwari | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 19,706 | 19,706 | - | - | Stock Appreciation Rights | |
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 19,527 | 19,527 | - | - | Stock Option | |
| OptimizeRx Corp | Doug Besch | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 19,527 | 19,527 | - | - | Stock Option | |
| Tenable Holdings Inc | Arthur W. Coviello | Director | Sale of securities on an exchange or to another person at price $ 35.02 per share. | 03 Oct 2022 | 19,166 | 25,879 (0%) | 0% | 35.0 | 671,193 | Common Stock |
| Tenable Holdings Inc | Arthur W. Coviello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 19,166 | 8 | - | - | Stock Option (right to buy) | |
| Tenable Holdings Inc | Arthur W. Coviello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.97 per share. | 03 Oct 2022 | 19,166 | 45,045 (0%) | 0% | 11.0 | 210,251 | Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 03 Oct 2022 | 18,899 | 712,440 (0%) | 0% | 10.4 | 196,739 | Class A Common Stock |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 18,750 | 21,838 | - | 0 | Common Shares | |
| ClearSign Tech Corp | Gary DiElsi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 18,459 | 18,459 | - | - | Restricted Stock Units | |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 18,223 | 947,212 | - | - | Stock Option (Right to Buy) | |
| Woodward Inc | Mark D. Hartman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 18,091 | 18,091 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 17,978 | 53,936 | - | - | Restricted Stock Units | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 17,978 | 284,201 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| ZoomInfo Tech Inc | Joseph Christopher Hays | Pres, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 41.97 per share. | 03 Oct 2022 | 17,797 | 577,329 | - | 42.0 | 746,853 | Common Stock |
| Netflix | Ted Sarandos | Director, Co-CEO & Chief Content Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 17,431 | 17,431 | - | - | Non-Qualified Stock Option (right to buy) | |
| Axe Compute Inc | Raymond F. Vennare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 16,667 | 78,730 (1%) | 0% | 0 | Common Stock | |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 03 Oct 2022 | 15,833 | 16,076 (0%) | 0% | 6.4 | 101,490 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 15,833 | 47,501 | - | - | Stock Option (right to buy) | |
| Cross Country Healthcares Inc - Registered Shares | William Burns | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 03 Oct 2022 | 15,525 | 216,721 (0%) | 0% | 31 | 481,275 | Common Stock |
| Adeia Inc | V. Sue Molina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 15,415 | 22,862 (0%) | 0% | 0 | Common Stock | |
| OppFi Inc (Class A) | Christopher McKay | Chief Risk & Analytics Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 15,403 | 15,403 | - | 0 | Class A Common Stock | |
| OppFi Inc (Class A) | Christopher McKay | Chief Risk & Analytics Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 15,403 | 46,210 | - | - | Restricted Stock Units | |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.91 per share. | 03 Oct 2022 | 15,351 | 505,465 (0%) | 0% | 33.9 | 520,552 | Common Stock |
| Procore Tech Inc | Craig F. Courtemanche | Director, CEO & President, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 49.77 per share. | 03 Oct 2022 | 15,340 | 3,691,947 | - | 49.8 | 763,472 | Common Stock |
| Rockwell | Blake D. Moret | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 15,311 | 15,311 | - | - | Performance Shares | |
| LifeStance Health Grp Inc | Warren Gouk | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 7.02 per share. | 03 Oct 2022 | 15,106 | 6,043,521 | - | 7.0 | 106,044 | Common Stock |
| Federated Hermes Inc (Class B) | Saker Anwar Nusseibeh | CEO, Hermes Fund Managers Ltd. | Sale of securities on an exchange or to another person at price $ 33.49 per share. | 03 Oct 2022 | 15,017 | 257,797 (0%) | 0% | 33.5 | 502,858 | Class B Common Stock |
| ATI Inc | Robert S. Wetherbee | Director, Board Chair, President and CEO | 03 Oct 2022 | 15,000 | 343,753 (0%) | 0% | 27.1 | 406,950 | Common Stock, par value $0.10 per share | |
| Insulet | Shacey Petrovic | Director | 03 Oct 2022 | 15,000 | 28,695 (0%) | 0% | 46.2 | 693,300 | Common Stock | |
| Insulet | Shacey Petrovic | Director | 03 Oct 2022 | 15,000 | 10,445 | - | - | Employee Stock Option (Right to Buy) | ||
| Insulet | Shacey Petrovic | Director | 03 Oct 2022 | 15,000 | 13,695 (0%) | 0% | 231.8 | 3,477,000 | Common Stock | |
| International Seaways Inc | Lois K. Zabrocky | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 14,942 | 0 | - | - | Stock Option (Right to Buy) | |
| International Seaways Inc | Lois K. Zabrocky | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.93 per share. | 03 Oct 2022 | 14,942 | 126,921 (0%) | 0% | 30.9 | 462,156 | Common Stock, no par value per share |
| Cross Country Healthcares Inc - Registered Shares | Susan E. Ball | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 03 Oct 2022 | 14,901 | 155,896 (0%) | 0% | 30 | 447,030 | Common Stock |
| Xos Inc | Robert Ferber | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 03 Oct 2022 | 14,533 | 521,446 | - | 1.1 | 15,841 | Common Stock |
| Cross Country Healthcares Inc - Registered Shares | William Burns | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 03 Oct 2022 | 14,158 | 232,246 (0%) | 0% | 30 | 424,740 | Common Stock |
| MongoDB Inc (Class A) | Dwight Merriman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.72 per share. | 03 Oct 2022 | 14,095 | 1,337,049 (2%) | 0% | 5.7 | 80,623 | Class A Common Stock |
| MongoDB Inc (Class A) | Dwight Merriman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 14,095 | 70,475 | - | - | Stock Option (Right to Buy) | |
| International Seaways Inc | Lois K. Zabrocky | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.99 per share. | 03 Oct 2022 | 14,090 | 112,831 (0%) | 0% | 35.0 | 493,009 | Common Stock, no par value per share |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.84 per share. | 03 Oct 2022 | 14,000 | 59,950 | - | 2.8 | 39,760 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 14,000 | 14,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 14,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.13 per share. | 03 Oct 2022 | 13,801 | 45,950 | - | 4.1 | 56,998 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 13,801 | 13,801 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 13,801 | 0 | - | - | Stock Options (Right to Buy) | |
| Jazz Pharma PLC | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 134.02 per share. | 03 Oct 2022 | 13,791 | 405,422 (0%) | 0% | 134.0 | 1,848,307 | Ordinary Shares |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 13,777 | 965,435 | - | - | Stock Option (Right to Buy) | |
| Woodward Inc | A. Christopher Fawzy | VP, Gen Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 13,555 | 13,555 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Biohaven Ltd | Robert J. Hugin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 03 Oct 2022 | 12,959 | 12,959 | - | 7.5 | 97,193 | Common Shares |
| TrueBlue Inc | Taryn R. Owen | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 12,943 | 82,039 (0%) | 0% | 0 | Common Stock | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.40 per share. | 03 Oct 2022 | 12,845 | 121,739 | - | 34.4 | 441,868 | Common Stock, $0.01 par value per share |
| Microchip Tech | Ganesh Moorthy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 12,699 | 12,699 | - | - | Restricted Stock Units | |
| Microchip Tech | Ganesh Moorthy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 12,699 | 12,699 | - | - | Performance Stock Units | |
| NexPoint Diversified Real Estate Trust | James D. Dondero | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.56 per share. | 03 Oct 2022 | 12,619 | 3,761,574 (8%) | 0% | 12.6 | 158,495 | Common Stock |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 03 Oct 2022 | 12,612 | 30,950 | - | 6.4 | 80,338 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 12,612 | 12,612 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 12,612 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 03 Oct 2022 | 12,500 | 133,461 | - | 0.5 | 6,750 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 12,500 | 12,500 | - | - | Stock Options (Right to Buy) | |
| Peloton Interactive Inc | Allen J. Klingsick | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 12,456 | 12,456 | - | - | Stock Option (right to buy Class A Common Stock) | |
| Peloton Interactive Inc | Allen J. Klingsick | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Oct 2022 | 12,456 | 0 | - | - | Stock Option (right to buy Class A Common Stock) | |
| Woodward Inc | Roger A. Ross | President, Aero Systems | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 12,343 | 12,343 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Dave & Buster`s Entertainment Inc | Kevin M. Sheehan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 12,320 | 7,680 | - | - | Performance Stock Unit | |
| Dave & Buster`s Entertainment Inc | Kevin M. Sheehan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 12,320 | 223,538 (0%) | 0% | 0 | Common Stock | |
| Alphabet (Class A) | Prabhakar Raghavan | Senior Vice President | 03 Oct 2022 | 12,237 | 64,343 (0%) | 0% | 97.3 | 1,190,979 | Class C Capital Stock | |
| Harmony Biosciences Holdings Inc | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2022 | 12,173 | 12,173 | - | 8.2 | 100,062 | Common Stock | |
| Woodward Inc | Sagar A. Patel | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 12,134 | 12,134 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Sale of securities on an exchange or to another person at price $ 65.81 per share. | 03 Oct 2022 | 12,020 | 79,235 (0%) | 0% | 65.8 | 791,088 | Class A Common Stock |
| Woodward Inc | Terence J. Voskuil | President, ATS | 03 Oct 2022 | 12,018 | 12,018 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Biohaven Ltd | Julia P. Gregory | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 03 Oct 2022 | 11,975 | 16,142 | - | 7.5 | 89,813 | Common Shares |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 03 Oct 2022 | 11,975 | 1,307,971 | - | 7.5 | 89,813 | Common Shares |
| ACV Auctions Inc (Class A) | Vikas Mehta | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Oct 2022 | 11,846 | 919,645 | - | - | Class B Common Stock | |
| International Flavors & Fragrances Inc | Glenn R. Richter | CFO | 03 Oct 2022 | 11,812 | 23,624 | - | - | Restricted Stock Units | ||
| International Flavors & Fragrances Inc | Glenn R. Richter | CFO | 03 Oct 2022 | 11,812 | 11,812 (0%) | 0% | 0 | Common Stock | ||
| Oscar Health Inc (Class A) | Victoria Baltrus | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 03 Oct 2022 | 11,729 | 14,532 | - | 5.0 | 58,176 | Class A Common Stock |
| Biohaven Ltd | Kishan Mehta | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. | 03 Oct 2022 | 11,716 | 22,662 | - | 7 | 82,012 | Common Shares |
| Palo Alto | Nir Zuk | Director, EVP, Chief Technology Officer | 03 Oct 2022 | 11,500 | 1,943,436 (1%) | 0% | 169.2 | 1,945,858 | Common Stock | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 11,450 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 11,450 | 11,450 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 03 Oct 2022 | 11,450 | 34,838 | - | 6.4 | 72,937 | Common Shares |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 03 Oct 2022 | 11,369 | 192,519 | - | 2.9 | 32,934 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.38 per share. | 03 Oct 2022 | 11,369 | 181,150 | - | 20.4 | 231,757 | Class A Common Stock |
| DoubleVerify Holdings Inc | Nicola Allais | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 11,249 | 726,099 | - | - | Options (Rights to Buy) | |
| DoubleVerify Holdings Inc | Nicola Allais | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.01 per share. | 03 Oct 2022 | 11,249 | 62,584 | - | 2.0 | 22,610 | Common Stock |
| Peloton Interactive Inc | Allen J. Klingsick | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Oct 2022 | 11,113 | 0 | - | - | Stock Option (right to buy Class A Common Stock) | |
| Peloton Interactive Inc | Allen J. Klingsick | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 11,113 | 11,113 | - | - | Stock Option (right to buy Class A Common Stock) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 03 Oct 2022 | 11,042 | 23,796 | - | 7.5 | 82,815 | Common Shares |
| Precipio Inc | Ilan Danieli | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 03 Oct 2022 | 11,000 | 40,546 (0%) | 0% | 0.9 | 9,570 | Common Stock |
| Newmont | Thomas Ronald Palmer | Director, President & CEO | 03 Oct 2022 | 11,000 | 232,949 (0%) | 0% | 42.7 | 469,810 | Common Stock, $1.60 par value | |
| Monolithic Power | Michael R. Hsing | Director, CEO | Sale of securities on an exchange or to another person at price $ 372.60 per share. | 03 Oct 2022 | 10,960 | 1,005,883 (2%) | 0% | 372.6 | 4,083,696 | Common Stock |
| MongoDB Inc (Class A) | Dwight Merriman | Director | Sale of securities on an exchange or to another person at price $ 198.90 per share. | 03 Oct 2022 | 10,895 | 1,326,154 (2%) | 0% | 198.9 | 2,167,016 | Class A Common Stock |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.77 per share. | 03 Oct 2022 | 10,616 | 134,584 | - | 33.8 | 358,502 | Common Stock, $0.01 par value per share |
| Cross Country Healthcares Inc - Registered Shares | William Burns | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 03 Oct 2022 | 10,610 | 206,111 (0%) | 0% | 32 | 339,520 | Common Stock |
| P&G | R. Alexandra Keith | CEO - Beauty | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 10,525 | 10,525 | - | - | Stock Option (Right to Buy) | |
| Woodward Inc | Charles P. Blankenship | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 10,423 | 49,023 (0%) | 0% | 0 | Woodward, Inc. Common Stock | |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.69 per share. | 03 Oct 2022 | 10,418 | 181,150 | - | 21.7 | 225,994 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 03 Oct 2022 | 10,418 | 191,568 | - | 2.9 | 30,179 | Class A Common Stock |
| Vince Holding Corp | David Stefko | See Remarks | Sale of securities on an exchange or to another person at price $ 6.23 per share. | 03 Oct 2022 | 10,339 | 160,809 (1%) | 0% | 6.2 | 64,412 | Common Stock |
| Medical Properties Trust Inc | R. Steven Hamner | Director, Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.84 per share. | 03 Oct 2022 | 10,272 | 1,940,670 (0%) | 0% | 11.8 | 121,620 | Common stock, par value $0.001 |
| ACV Auctions Inc (Class A) | George G. Chamoun | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.68 per share. | 03 Oct 2022 | 10,256 | 220,559 | - | 7.7 | 78,766 | Class A Common Stock |
| Agenus Inc | Wadih Jordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 10,102 | 239,944 | - | - | Deferred Stock Units | |
| Cadiz Inc | Geoffrey T. Grant | Director | Grant, award, or other acquisition of securities at price $ 1.86 per share. | 03 Oct 2022 | 10,081 | 508,787 (1%) | 0% | 1.9 | 18,751 | Common Stock |
| Cadiz Inc | Winston H. Hickox | Director | Grant, award, or other acquisition of securities at price $ 1.86 per share. | 03 Oct 2022 | 10,081 | 155,894 (0%) | 0% | 1.9 | 18,751 | Common Stock |
| Cadiz Inc | Keith Brackpool | Director | Grant, award, or other acquisition of securities at price $ 1.86 per share. | 03 Oct 2022 | 10,081 | 1,921,606 (7%) | 0% | 1.9 | 18,751 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Bruce R. Chizen | Director | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 03 Oct 2022 | 10,000 | 24,162 | - | 15.1 | 151,137 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Bruce R. Chizen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 338,640 | - | - | Stock Option (right to buy) | |
| ChargePoint Holdings Inc (Class A) | Bruce R. Chizen | Director | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 03 Oct 2022 | 10,000 | 747,256 | - | 15.1 | 151,127 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Bruce R. Chizen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. | 03 Oct 2022 | 10,000 | 34,162 | - | 0.8 | 7,600 | Common Stock |
| Biohaven Ltd | Kishan Mehta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 03 Oct 2022 | 10,000 | 34,378 | - | 1.9 | 18,600 | Common Shares |
| Biohaven Ltd | Kishan Mehta | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 10,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kishan Mehta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Cytokinetics Inc | Robert I. Blum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.40 per share. | 03 Oct 2022 | 10,000 | 406,089 (0%) | 0% | 50.4 | 504,000 | Common Stock |
| Cytokinetics Inc | Robert I. Blum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.96 per share. | 03 Oct 2022 | 10,000 | 416,089 (0%) | 0% | 8.0 | 79,600 | Common Stock |
| Cytokinetics Inc | Robert I. Blum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 19,208 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | 03 Oct 2022 | 10,000 | 10,000 | - | 0 | Class A Common Stock | ||
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | 03 Oct 2022 | 10,000 | 3,251,417 | - | - | Class B Common Stock | ||
| Evolv Tech Holdings Inc (Class A) | Anthony John De Rosa | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 03 Oct 2022 | 10,000 | 0 | - | 2.1 | 20,671 | Class A Common Stock |
| Evolv Tech Holdings Inc (Class A) | Anthony John De Rosa | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 1,039,895 | - | - | Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Anthony John De Rosa | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 03 Oct 2022 | 10,000 | 10,000 | - | 0.4 | 4,200 | Class A Common Stock |
| Marvell Tech Inc | Nariman Yousefi | EVP, Automotive, Coherent DSP | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 03 Oct 2022 | 10,000 | 274,144 (0%) | 0% | 45 | 450,000 | Common Stock |
| Transmedics Grp Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.74 per share. | 03 Oct 2022 | 10,000 | 5,714 (0%) | 0% | 41.7 | 417,400 | Common Stock |
| Transmedics Grp Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Grp Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.21 per share. | 03 Oct 2022 | 10,000 | 15,714 (0%) | 0% | 2.2 | 22,100 | Common Stock |
| Veeva Systems Inc (Class A) | Matthew J. Wallach | Director | 03 Oct 2022 | 10,000 | 12,546 (0%) | 0% | 0 | Class A Common Stock | ||
| Veeva Systems Inc (Class A) | Matthew J. Wallach | Director | 03 Oct 2022 | 10,000 | 130,000 | - | - | Class B Common Stock | ||
| Veeva Systems Inc (Class A) | Matthew J. Wallach | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 140,000 | - | - | Class B Common Stock | |
| Veeva Systems Inc (Class A) | Matthew J. Wallach | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 50,000 | - | - | Stock Option (right to buy) | |
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,973 | 9,973 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Doug Besch | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,973 | 9,973 | - | - | Restricted Stock Units | |
| Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,862 | 153,714 | - | - | Deferred Stock Units | |
| Concentrix Corp | Dennis J. Polk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 9,824 | 4,416 | - | - | Employee Stock Option (Right to Buy) | |
| Concentrix Corp | Dennis J. Polk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.14 per share. | 03 Oct 2022 | 9,824 | 26,342 | - | 48.1 | 472,927 | Common Stock |
| DoubleVerify Holdings Inc | Nicola Allais | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.92 per share. | 03 Oct 2022 | 9,774 | 52,810 | - | 27.9 | 272,915 | Common Stock |
| Harmony Biosciences Holdings Inc | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2022 | 9,739 | 0 | - | - | Stock Option | ||
| P&G | Shailesh G. Jejurikar | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,727 | 10,006 (0%) | 0% | 0 | Common Stock | |
| Biohaven Ltd | Michael T. Heffernan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 03 Oct 2022 | 9,699 | 15,178 | - | 7.5 | 72,743 | Common Shares |
| Biohaven Ltd | Vlad Coric | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 9,565 | 9,565 | - | 0 | Common Shares | |
| Harmony Biosciences Holdings Inc | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 03 Oct 2022 | 9,382 | 2,791 | - | 44.4 | 417,004 | Common Stock | |
| Filana Therapeutics Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 9,376 | 40,624 | - | - | Common Stock | |
| Filana Therapeutics Inc | Nadav Friedmann | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.95 per share. | 03 Oct 2022 | 9,376 | 79,910 (0%) | 0% | 0.9 | 8,907 | Common Stock |
| Microchip Tech | Steve Sanghi | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,290 | 9,290 | - | - | Performance Stock Units | |
| Microchip Tech | Steve Sanghi | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,289 | 9,289 | - | - | Restricted Stock Units | |
| Urban Edge Properties | Katherine M. Sandstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,233 | 9,233 | - | - | LTIP Units | |
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,010 | 9,010 | - | - | Employee Stock Option (right to buy) | |
| Biohaven Ltd | Julia P. Gregory | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.33 per share. | 03 Oct 2022 | 9,000 | 19,117 | - | 2.3 | 20,970 | Common Shares |
| Biohaven Ltd | Julia P. Gregory | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.06 per share. | 03 Oct 2022 | 9,000 | 28,117 | - | 3.1 | 27,540 | Common Shares |
| Biohaven Ltd | Julia P. Gregory | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 9,000 | 9,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Julia P. Gregory | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 9,000 | 9,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Julia P. Gregory | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 9,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Julia P. Gregory | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 9,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.33 per share. | 03 Oct 2022 | 9,000 | 1,310,946 | - | 2.3 | 20,970 | Common Shares |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 9,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.06 per share. | 03 Oct 2022 | 9,000 | 1,319,946 | - | 3.1 | 27,540 | Common Shares |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 9,000 | 9,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 9,000 | 9,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 9,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 03 Oct 2022 | 8,968 | 531,290 (0%) | 0% | 11.1 | 99,201 | Common Stock |
| Procore Tech Inc | Craig F. Courtemanche | Director, CEO & President, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 49.03 per share. | 03 Oct 2022 | 8,860 | 3,683,087 | - | 49.0 | 434,406 | Common Stock |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 8,843 | 301,427 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 8,843 | 26,529 | - | - | Restricted Stock Units | |
| P&G | Andre Schulten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 8,755 | 36,085 (0%) | 0% | 0 | Common Stock | |
| Honest Co Inc (The ) | Janis Hoyt | Chief People Officer | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 03 Oct 2022 | 8,698 | 341,348 | - | 3.5 | 30,269 | Common Stock |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Sale of securities on an exchange or to another person at price $ 65.33 per share. | 03 Oct 2022 | 8,680 | 91,255 (0%) | 0% | 65.3 | 567,029 | Class A Common Stock |
| FTC Solar Inc | Patrick M. Cook | Chief Commercial Officer | 03 Oct 2022 | 8,646 | 189,719 | - | 2.8 | 24,641 | Common Stock | |
| CSW Industrials Inc | Joseph B. Armes | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 8,629 | 65,549 (0%) | 0% | 0 | Common Stock | |
| P&G | Matthew W. Janzaruk | SVP - Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 8,488 | 8,488 | - | - | Stock Option (Right to Buy) | |
| Green Plains Inc | Grant D. Kadavy | EVP Commercial Operations | 03 Oct 2022 | 8,265 | 8,265 (0%) | 0% | 30.2 | 250,016 | Common Stock | |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 8,094 | 336,175 | - | - | Options (Rights to Buy) | |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Sale of securities on an exchange or to another person at price $ 24.27 per share. | 03 Oct 2022 | 8,094 | 10,426 | - | 24.3 | 196,466 | Common Stock |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.49 per share. | 03 Oct 2022 | 8,094 | 18,520 | - | 4.5 | 36,342 | Common Stock |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 03 Oct 2022 | 8,094 | 10,426 | - | 23.2 | 187,503 | Common Stock |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.49 per share. | 03 Oct 2022 | 8,094 | 18,520 | - | 4.5 | 36,342 | Common Stock |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 8,094 | 328,081 | - | - | Options (Rights to Buy) | |
| Rigetti Computing Inc | Alissa Fitzgerald | Director | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 03 Oct 2022 | 8,000 | 67,436 | - | 1.8 | 14,640 | Common Stock |
| Rigetti Computing Inc | Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 8,000 | 180,747 | - | - | Stock Option (right to buy) | |
| Rigetti Computing Inc | Alissa Fitzgerald | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 03 Oct 2022 | 8,000 | 75,436 | - | 0.3 | 2,176 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Sale of securities on an exchange or to another person at price $ 22.43 per share. | 03 Oct 2022 | 8,000 | 88,683 | - | 22.4 | 179,440 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 03 Oct 2022 | 8,000 | 96,683 | - | 4.1 | 32,960 | Common Stock |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 8,000 | 101,456 | - | - | Stock Option (Right to Buy) | |
| Gartner | Raul E. Cesan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Oct 2022 | 8,000 | 8,000 (0%) | 0% | 0 | Common Stock | |
| Gartner | Raul E. Cesan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Oct 2022 | 8,000 | 66,563 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharma PLC | Bruce C. Cozadd | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 135.80 per share. | 03 Oct 2022 | 7,748 | 374,028 (0%) | 0% | 135.8 | 1,052,213 | Ordinary Shares |
| OppFi Inc (Class A) | Christopher McKay | Chief Risk & Analytics Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 7,701 | 41,804 | - | 0 | Class A Common Stock | |
| OppFi Inc (Class A) | Christopher McKay | Chief Risk & Analytics Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 7,701 | 38,509 | - | - | Restricted Stock Unit | |
| Beam Global | Anthony L. Posawatz | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 03 Oct 2022 | 7,700 | 64,895 (1%) | 0% | 12.5 | 96,250 | Common Stock |
| Dave & Buster`s Entertainment Inc | Kevin M. Sheehan | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Oct 2022 | 7,680 | 0 | - | - | Performance Stock Unit | |
| Biohaven Ltd | Kishan Mehta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 03 Oct 2022 | 7,500 | 24,378 | - | 2.6 | 19,350 | Common Shares |
| Biohaven Ltd | Kishan Mehta | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 7,500 | 7,500 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kishan Mehta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 7,500 | 0 | - | - | Stock Options (Right to Buy) | |
| Agenus Inc | Susan B. Hirsch | Director | Grant, award, or other acquisition of securities at price $ 2.60 per share. | 03 Oct 2022 | 7,216 | 101,486 (0%) | 0% | 2.6 | 18,747 | Common Stock |
| P&G | Gary A. Coombe | CEO - Grooming | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 7,198 | 36,686 (0%) | 0% | 0 | Common Stock | |
| Prologis | James B. Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 7,140 | 7,140 (0%) | 0% | - | Common Stock | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.88 per share. | 03 Oct 2022 | 7,075 | 277,126 (0%) | 0% | 32.9 | 232,626 | Common Stock $.01 Par Value ND |
| Netflix | Gregory K. Peters | COO and Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 6,973 | 6,973 | - | - | Non-Qualified Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.29 per share. | 03 Oct 2022 | 6,899 | 181,150 | - | 20.3 | 139,971 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Marshall Fordyce | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 03 Oct 2022 | 6,899 | 188,049 | - | 2.9 | 19,985 | Class A Common Stock |
| Gitlab Inc (Class A) | Michael McBride | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 51.63 per share. | 03 Oct 2022 | 6,832 | 889,674 | - | 51.6 | 352,736 | Class A Common Stock |
| Incyte | Susanne Schaffert | Director | 03 Oct 2022 | 6,751 | 6,751 | - | - | Non-Qualified Stock Option (right to buy) | ||
| P&G | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 6,746 | 39,640 (0%) | 0% | 0 | Common Stock | |
| Medical Properties Trust Inc | Emmett E. Mclean | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.84 per share. | 03 Oct 2022 | 6,590 | 1,904,206 (0%) | 0% | 11.8 | 78,026 | Common stock, par value $0.001 |
| Biohaven Ltd | Kishan Mehta | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 6,502 | 6,502 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kishan Mehta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.61 per share. | 03 Oct 2022 | 6,502 | 16,878 | - | 4.6 | 29,974 | Common Shares |
| Biohaven Ltd | Kishan Mehta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 6,502 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 6,500 | 12,326 | - | 0 | Common Shares | |
| ACV Auctions Inc (Class A) | Craig Anderson | CCDSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Oct 2022 | 6,416 | 153,595 | - | - | Class B Common Stock | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.54 per share. | 03 Oct 2022 | 6,384 | 121,739 | - | 35.5 | 226,887 | Common Stock, $0.01 par value per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 62.10 per share. | 03 Oct 2022 | 6,355 | 1,936 (0%) | 0% | 62.1 | 394,677 | Ordinary Shares, par value $0.01 per share |
| Urban Edge Properties | Katherine M. Sandstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 6,333 | 6,333 | - | - | LTIP Units | |
| Veeco Instruments Inc | William J. Miller | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.32 per share. | 03 Oct 2022 | 6,226 | 515,695 (1%) | 0% | 18.3 | 114,060 | Common Stock |
| Progress Software Corp | Yogesh K. Gupta | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 6,181 | 30,906 | - | - | Restricted Stock Units | |
| Progress Software Corp | Yogesh K. Gupta | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 6,181 | 89,071 (0%) | 0% | 0 | Common Stock | |
| Alphabet (Class A) | Prabhakar Raghavan | Senior Vice President | 03 Oct 2022 | 6,158 | 58,185 (0%) | 0% | 98.7 | 607,921 | Class C Capital Stock | |
| Honest Co Inc (The ) | Rick Rexing | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 03 Oct 2022 | 6,126 | 343,914 | - | 3.5 | 21,318 | Common Stock |
| Netflix | Spencer Adam Neumann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 6,100 | 6,100 | - | - | Non-Qualified Stock Option (right to buy) | |
| Biohaven Ltd | Julia P. Gregory | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.56 per share. | 03 Oct 2022 | 5,998 | 10,117 | - | 3.6 | 21,353 | Common Shares |
| Biohaven Ltd | Julia P. Gregory | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 5,998 | 5,998 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Julia P. Gregory | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 5,998 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.56 per share. | 03 Oct 2022 | 5,998 | 1,301,946 | - | 3.6 | 21,353 | Common Shares |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 5,998 | 5,998 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Gregory Hugh Bailey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 5,998 | 0 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 5,826 | 5,826 | - | 0 | Common Shares | |
| Xometry Inc (Class A) | Randolph Altschuler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.65 per share. | 03 Oct 2022 | 5,729 | 671,497 | - | 58.6 | 335,981 | Class A Common Stock |
| Grocery Outlet Holding Corp | Steven K. Wilson | SVP, Chief Purchasing Officer | 03 Oct 2022 | 5,555 | 155,993 (0%) | 0% | 33.5 | 185,926 | Common Stock | |
| Grocery Outlet Holding Corp | Steven K. Wilson | SVP, Chief Purchasing Officer | 03 Oct 2022 | 5,555 | 11,078 | - | - | Stock Options (Right to Buy) | ||
| Grocery Outlet Holding Corp | Steven K. Wilson | SVP, Chief Purchasing Officer | 03 Oct 2022 | 5,555 | 161,548 (0%) | 0% | 3.8 | 21,165 | Common Stock | |
| MGM Resorts International | Todd R. Meinert | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 5,554 | 5,554 | - | - | Restricted Stock Units | |
| Beam Global | Nancy C. Floyd | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 03 Oct 2022 | 5,500 | 13,992 (0%) | 0% | 12.5 | 68,750 | Common Stock |
| Beam Global | Peter Warner Davidson | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 03 Oct 2022 | 5,500 | 46,434 (0%) | 0% | 12.5 | 68,750 | Common Stock |
| Ranpak Holdings Corp (Class A) | Salil Seshadri | Director | Grant, award, or other acquisition of securities at price $ 3.40 per share. | 03 Oct 2022 | 5,483 | 330,880 (0%) | 0% | 3.4 | 18,642 | Class A common stock |
| Ranpak Holdings Corp (Class A) | Alicia M. Tranen | Director | Grant, award, or other acquisition of securities at price $ 3.40 per share. | 03 Oct 2022 | 5,483 | 113,688 (0%) | 0% | 3.4 | 18,642 | Class A common stock |
| Ranpak Holdings Corp (Class A) | Kurt Zumwalt | Director | 03 Oct 2022 | 5,483 | 37,925 (0%) | 0% | 3.4 | 18,642 | Class A common stock | |
| Ranpak Holdings Corp (Class A) | Pamela El | Director | Grant, award, or other acquisition of securities at price $ 3.40 per share. | 03 Oct 2022 | 5,483 | 24,171 (0%) | 0% | 3.4 | 18,642 | Class A common stock |
| ACV Auctions Inc (Class A) | Vikas Mehta | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.68 per share. | 03 Oct 2022 | 5,471 | 148,853 | - | 7.7 | 42,017 | Class A Common Stock |
| Otis Worldwide | Anurag Maheshwari | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 5,445 | 5,445 | - | - | RSUs | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Sale of securities on an exchange or to another person at price $ 54.61 per share. | 03 Oct 2022 | 5,443 | 422,615 (0%) | 0% | 54.6 | 297,242 | Class A Common Stock |
| Agilon Health Inc | Priscilla Kasenchak | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 5,413 | 5,413 | - | - | Options (Rights to Buy) | |
| Biohaven Ltd | Kishan Mehta | Director | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 5,320 | 5,320 | - | 0 | Common Shares | |
| Progress Software Corp | Yogesh K. Gupta | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 5,282 | 15,846 | - | - | Restricted Stock Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.